# CVM GFI #61 Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-61-special-considerations-incentives-and-programs-to-support-the-approval-of-new-animal-drugs-for-minor-uses-and-for-minor-species/7cbf17f7-6c8b-4e68-9f84-7be2176b22f0 > FDA guidance document: CVM GFI #61 Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species. Issue date: December 22, 2023. Get complete insights and analysis. --- ## Details - Title: CVM GFI #61 Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species - Communication Type: Guidance Document - Product Type: veterinary - Office Name: Center for Veterinary Medicine - Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4 - Issue Date: 2023-12-22 - Comment Close Date: 2021-01-11 - Last Changed: 2023-12-21 - Docket Number: FDA-1997-D-0444 ## Related Documents - [CVM GFI #265 Use of Data from Foreign Investigational Studies to Support Effectiveness of New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-265-use-of-data-from-foreign-investigational-studies-to-support-effectiveness-of-new-animal-drugs/f6cb70ad-ba2c-4653-958c-74dd08a7f819) - [CVM GFI #266 Use of Real-World Data and Real-World Evidence to Support Effectiveness of New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-266-use-of-real-world-data-and-real-world-evidence-to-support-effectiveness-of-new-animal-drugs/525f6470-8ff5-452d-90dd-0083fd6675cc) - [CVM GFI #199 Animal Generic Drug User Fees and Fee Waivers and Reductions](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-199-animal-generic-drug-user-fees-and-fee-waivers-and-reductions/6fc52a11-514e-4e9d-90b6-c79ef576ec6f)